COMP <GO>
MET vs MS // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
MetLife Inc. (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: MET 8
— MS 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MS
LAST: $100.02 (-0.80%) • MKT CAP: $64.08B
options-implied-move
7.40%
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
options-implied-move
7.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MET VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MET | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.60% | 3.00% | -1.40 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 55.0x | 31.0x | +24.00 | MS | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | -7.25% | +29.25 | MET | /fcf-yield <GO> |
| Operating Margin | 75.00% | 24.60% | +50.40 | MET | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 20.20% | +47.80 | MET | /net-margins <GO> |
| Revenue Growth (YoY) | 8.50% | 5.50% | +3.00 | MET | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.36% | 2.21% | +0.15 | MET | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.46 | -0.01 | MS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | MET | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.40% | 7.00% | +0.40 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 43.3 | +9.77 | MET | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 1.04 | +0.12 | MET | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.8x | 16.5x | +2.30 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.08B | $298.41B | -$234.33B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MET REV | MS REV | MET GROSS % | MS GROSS % | MET FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $0 | 44.0% | — | $16.98B | -$17.89B |
| FY 2024 | $2.25B | $0 | 44.0% | — | $14.50B | $1.36B |
| FY 2023 | $2.23B | $0 | 44.0% | — | $13.62B | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MET // BETA 1.16
MS // BETA 1.04